United Kingdom· GB-APID-16444811000001103
Ondansetron 4mg/5ml oral solution sugar free
A ondansetron product containing ondansetron, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 19 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ondansetron is registered in 19 of 19 countries.
Countries holding a registration under ATC A04AA01 (ondansetron), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Ondansetron · ATC A04AA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ondansetron costs, country by country.
Normalised to the WHO defined daily dose (16 mg), the median price runs from $0.23 in United States to $18.43 in Switzerland — a ×79 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ondansetron · price per daily dose (16 mg)
USD · FX 28 Sept 2026
- CH Switzerland$18.43
- IT Italy$14.68
- FR France$5.36
- US United States$0.23 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ondansetron
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- A04AA01
- ATC class
- Ondansetron
- Defined daily dose
- 16 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
841 interactions on record for ondansetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ondansetron · interactions on record
841 records
- 139 severe
- 240 moderate
- 6 minor
- 402 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ondansetron in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesondansetronMajor Pharmaceuticals
- CzechiaNOVETRONPHARMAGEN CZ s.r.o., Praha
- FinlandEmeondanAlfred E.Tiefenbacher GmbH & Co. KG
- CanadaACCEL-ONDANSETRONACCEL PHARMA INC
- BelgiumAvessaron 4 mgSandoz
- GermanyCellondanStadapharm Gmbh
- SpainONDANSETRON ACCORD 2 mg/ml SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- SwedenOndansetron 2care4 4 mg Munsönderfallande tablett2care4 ApS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ondansan, Ondansan I.V.
- Belgium · Ondansetron Ab, Ondansetron Accord Healthcare
- Bulgaria · Zofran, Зондарон
- Cyprus · Ondansetron Accord, Ondansetron Noridem
- Czechia · Novetron, Ondansetron Accord
- Germany · Cellondan, Ondansetron 1 A Pharma
- Denmark · Ondansetron "kalceks", Ondansetron "stada"
- Estonia · Ondansetron Accord, Ondansetron Basi
- Spain · Ondansetrón Accord, Ondansetron Aristo
- Finland · Ondansetron Accord, Ondansetron Accordpharma
- France · Ondansetron Accord, Ondansetron Arrow
- Greece · Cruzafen, Odasen
- Croatia · Ondansetron Kalceks, Ondanzetron Kabi
- Hungary · Emetron, Ondansetron Kabi
- Ireland · Emizof, Ondansetron Accord Healthcare Ireland
- Iceland · Cinveron, Ondansetron Bluefish
- Italy · Emistop, Ondansetron Accord
- Lithuania · Ondansetron Accord, Ondansetron Basi
- Luxembourg · Avessaron, Ondansetron B. Braun
- Latvia · Emetron, Ondansetron Accord
- Malta · Emytron, Ondansetron Accord Healthcare Ireland
- Netherlands · Ondansetron Accord, Ondansetron Aspire
- Norway · Ondansetron Accord, Ondansetron Accordpharma
- Poland · Atossa, Ondansetron Accord
- Portugal · Danevon, Emytron
- Romania · Ondansetron Aurobindo, Ondansetron Kabi
- Sweden · Ondansetron Accord, Ondansetron Accordpharma
- Slovenia · Ondansetron Accord, Ondansetron Baxter
- Slovakia · Ondansetron Accord, Ondansetron B. Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e821f1ab-7976-4295-908e-7cb65374cedc GET /v1/drugs/e821f1ab-7976-4295-908e-7cb65374cedc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "16444811000001103",
"desc": "Ondansetron 4mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd)",
"form": "Oral solution",
"vpid": "36564311000001109",
"source": "dmd",
"vtm_id": "776993002",
"strength": "800 microgram",
"substance": "Ondansetron",
"ingredient": "Ondansetron hydrochloride",
"supplier_code": "3144701000001104"
}See everything about ondansetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.